Earnings Tweak for Tariffs Draws Scrutiny to Urbaser's Debt Sale
Urbaser, which is owned by private equity firm Platinum Equity, is seeking to raise €2.3 billion ($2.7 billion) in fresh debt from investors. An offering memorandum seen by Bloomberg included a provision that would have allowed it to tweak Ebitda, or earnings before interest, tax, depreciation and amortization, to exclude the impact of tariffs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Braskem S.A. (BAK): A Bull Case Theory
We came across a bullish thesis on Braskem S.A. on Lasse's Substack by Lasse. In this article, we will summarize the bulls' thesis on BAK. Braskem S.A.'s share was trading at $3.2000 as of August 8th. BAK's trailing and forward P/E were 8.44 and 9.78, respectively according to Yahoo Finance. Pressmaster/ Braskem presents a compelling 'cycle + overhang' investment opportunity at fire-sale levels, offering significant upside if polyolefin spreads mean-revert or if there is binding environmental clarity or credible strategic interest. The company's mid-cycle EBITDA is estimated at $1.9–$2.0 billion, supported by normalized polyolefin spreads and utilization rates, implying an enterprise value of roughly $11.4–$12.0 billion at a 6x multiple. With adjusted net debt around $8.7 billion, this translates into an equity value of $2.7–$3.3 billion, or approximately $6.7–$8.2 per ADR, compared to current prices near $3. Braskem's earnings are highly sensitive to polyolefin spread changes, with every $50/ton increase potentially adding $450–$500 million in EBITDA, translating to a material EV and share price uplift. Two main catalysts could unlock value: binding environmental resolution that limits cash outflows related to the Alagoas disaster, and a strategic sale or stake transaction that could reset earnings expectations and valuation multiples. While Brazil's import tariff increases on chemicals provide some tailwind, the thesis does not rely on this. The downside scenario assumes prolonged weak spreads and higher-than-expected environmental liabilities, potentially pushing equity values toward $2.0–$2.5 per ADR, whereas a bull case with faster normalization and a binding cap could push values above $11 per ADR, though governance and country risk temper this upside. Key triggers include sustained spread and utilization improvements, environmental settlement clarity, and M&A developments. Risks include prolonged commodity weakness, environmental cost overruns, and liquidity stress. Overall, Braskem is a through-cycle cash generator priced as if recovery is impossible, presenting an attractive risk/reward for disciplined investors prepared to act on validated catalysts. Previously, we covered a bullish thesis on Rayonier Advanced Materials Inc. (RYAM) by Value Degen in June 2025, which highlighted its cyclical nature and insider buying as key drivers. The company's stock price has appreciated by approximately 17.5% since our coverage, reflecting growing investor confidence. Lasse shares a similar thesis on Braskem, focusing on environmental clarity and strategic catalysts in a different industry, presenting a distinct opportunity. Braskem S.A. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 11 hedge fund portfolios held BAK at the end of the first quarter which was 13 in the previous quarter. While we acknowledge the potential of BAK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None.
Yahoo
a day ago
- Yahoo
Braskem S.A. (BAK): A Bull Case Theory
We came across a bullish thesis on Braskem S.A. on Lasse's Substack by Lasse. In this article, we will summarize the bulls' thesis on BAK. Braskem S.A.'s share was trading at $3.2000 as of August 8th. BAK's trailing and forward P/E were 8.44 and 9.78, respectively according to Yahoo Finance. Pressmaster/ Braskem presents a compelling 'cycle + overhang' investment opportunity at fire-sale levels, offering significant upside if polyolefin spreads mean-revert or if there is binding environmental clarity or credible strategic interest. The company's mid-cycle EBITDA is estimated at $1.9–$2.0 billion, supported by normalized polyolefin spreads and utilization rates, implying an enterprise value of roughly $11.4–$12.0 billion at a 6x multiple. With adjusted net debt around $8.7 billion, this translates into an equity value of $2.7–$3.3 billion, or approximately $6.7–$8.2 per ADR, compared to current prices near $3. Braskem's earnings are highly sensitive to polyolefin spread changes, with every $50/ton increase potentially adding $450–$500 million in EBITDA, translating to a material EV and share price uplift. Two main catalysts could unlock value: binding environmental resolution that limits cash outflows related to the Alagoas disaster, and a strategic sale or stake transaction that could reset earnings expectations and valuation multiples. While Brazil's import tariff increases on chemicals provide some tailwind, the thesis does not rely on this. The downside scenario assumes prolonged weak spreads and higher-than-expected environmental liabilities, potentially pushing equity values toward $2.0–$2.5 per ADR, whereas a bull case with faster normalization and a binding cap could push values above $11 per ADR, though governance and country risk temper this upside. Key triggers include sustained spread and utilization improvements, environmental settlement clarity, and M&A developments. Risks include prolonged commodity weakness, environmental cost overruns, and liquidity stress. Overall, Braskem is a through-cycle cash generator priced as if recovery is impossible, presenting an attractive risk/reward for disciplined investors prepared to act on validated catalysts. Previously, we covered a bullish thesis on Rayonier Advanced Materials Inc. (RYAM) by Value Degen in June 2025, which highlighted its cyclical nature and insider buying as key drivers. The company's stock price has appreciated by approximately 17.5% since our coverage, reflecting growing investor confidence. Lasse shares a similar thesis on Braskem, focusing on environmental clarity and strategic catalysts in a different industry, presenting a distinct opportunity. Braskem S.A. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 11 hedge fund portfolios held BAK at the end of the first quarter which was 13 in the previous quarter. While we acknowledge the potential of BAK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Blink Charging Earnings: What To Look For From BLNK
EV charging infrastructure provider Blink Charging (NASDAQ:BLNK) will be announcing earnings results this Monday after market close. Here's what to expect. Blink Charging missed analysts' revenue expectations by 24.3% last quarter, reporting revenues of $20.75 million, down 44.8% year on year. It was a disappointing quarter for the company, with a significant miss of analysts' adjusted operating income estimates and a significant miss of analysts' EBITDA estimates. Is Blink Charging a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Blink Charging's revenue to decline 36.2% year on year to $21.21 million, a reversal from the 1.3% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.17 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Blink Charging has missed Wall Street's revenue estimates four times over the last two years. Looking at Blink Charging's peers in the renewable energy segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Generac delivered year-on-year revenue growth of 6.3%, beating analysts' expectations by 3.4%, and Sunrun reported revenues up 8.7%, topping estimates by 4%. Generac traded up 28.9% following the results while Sunrun was also up 33.2%. Read our full analysis of Generac's results here and Sunrun's results here. There has been positive sentiment among investors in the renewable energy segment, with share prices up 3.3% on average over the last month. Blink Charging is down 9.5% during the same time and is heading into earnings with an average analyst price target of $2.40 (compared to the current share price of $0.95). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
